PL2513060T3 - Krystaliczna postać α karbabenzopirydu - Google Patents

Krystaliczna postać α karbabenzopirydu

Info

Publication number
PL2513060T3
PL2513060T3 PL11725450T PL11725450T PL2513060T3 PL 2513060 T3 PL2513060 T3 PL 2513060T3 PL 11725450 T PL11725450 T PL 11725450T PL 11725450 T PL11725450 T PL 11725450T PL 2513060 T3 PL2513060 T3 PL 2513060T3
Authority
PL
Poland
Prior art keywords
carbabenzpyride
alpha
crystalline form
crystalline
Prior art date
Application number
PL11725450T
Other languages
English (en)
Inventor
Filya Zhebrovska
Viktor Margitych
Grygorii Kostiuk
Oleh Syarkevych
Mykhailo Vanat
Original Assignee
Farmak Int Holding Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmak Int Holding Gmbh filed Critical Farmak Int Holding Gmbh
Publication of PL2513060T3 publication Critical patent/PL2513060T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
PL11725450T 2010-06-17 2011-06-15 Krystaliczna postać α karbabenzopirydu PL2513060T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/IB2010/001956 WO2011158058A1 (en) 2010-06-17 2010-06-17 α-CRYSTALLINE FORM OF CARBABENZPYRIDE
EP11725450.8A EP2513060B1 (en) 2010-06-17 2011-06-15 Alpha-crystalline form of carbabenzpyride
PCT/EP2011/059922 WO2011157743A1 (en) 2010-06-17 2011-06-15 Alpha-crystalline form of carbabenzpyride

Publications (1)

Publication Number Publication Date
PL2513060T3 true PL2513060T3 (pl) 2014-02-28

Family

ID=43607637

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11725450T PL2513060T3 (pl) 2010-06-17 2011-06-15 Krystaliczna postać α karbabenzopirydu

Country Status (7)

Country Link
US (1) US8404857B2 (pl)
EP (1) EP2513060B1 (pl)
CA (1) CA2790294C (pl)
EA (1) EA019080B9 (pl)
PL (1) PL2513060T3 (pl)
UA (1) UA104102C2 (pl)
WO (2) WO2011158058A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013170901A1 (en) 2012-05-18 2013-11-21 Farmak International Holding Gmbh N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
EA201792455A1 (ru) * 2017-12-06 2019-06-28 Открытое акционерное общество "Авексима" Нобазит кристаллический в форме ромбической сингонии и способ его получения
RU2689775C1 (ru) * 2018-11-02 2019-05-29 Открытое акционерное общество "Авексима" Способ промышленного производства N-метил-4-бензилкарбамидопиридиния йодида

Also Published As

Publication number Publication date
EP2513060B1 (en) 2013-09-11
US20120309978A1 (en) 2012-12-06
US8404857B2 (en) 2013-03-26
CA2790294C (en) 2013-05-28
UA104102C2 (en) 2013-12-25
EA019080B9 (ru) 2014-03-31
EA201270786A1 (ru) 2013-02-28
EP2513060A1 (en) 2012-10-24
WO2011158058A1 (en) 2011-12-22
WO2011157743A1 (en) 2011-12-22
EA019080B1 (ru) 2013-12-30
CA2790294A1 (en) 2011-12-22

Similar Documents

Publication Publication Date Title
HK1245110B (zh) 異喹啉酮的固體形式
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
AP3607A (en) Substituted imidazopyridazines
PT2539136T (pt) Poste de barreira e método de fabrico do mesmo
ZA201209407B (en) Modification of xylan
HK1171452A1 (en) Substituted pyrrolidine-2-carboxamides -2-
HK1178149A1 (en) Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4---
DK2786756T3 (en) Kombinationsterapi med en topoisomeraseinhibitor
ZA201206456B (en) Uses of dgati inhibitors
EP2633446A4 (en) IDENTIFICATION OF PHYSICAL LOCATIONS OF UNITS
TWM389827U (en) Improved structure of lamp
AP3429A (en) Substituted sodium-1h-pyrazole-5-olate
PT2542591T (pt) Derivados silílicos de polissacáridos
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
PL2513060T3 (pl) Krystaliczna postać α karbabenzopirydu
EP2536693A4 (en) SUBSTITUTED 2-IMIDAZOLIDONES AND THE LIKE
SG10201508549UA (en) Modified tamavidin
HK1160777A1 (en) Novel use of neohesperidoside
GB201011285D0 (en) Uses of carpet
TWM386036U (en) Structure of freshness-maintaining box
TWM388919U (en) Structure of endoscope
TWM386182U (en) Improved structure of seal
TWM390349U (en) Structure of door-in-door
TWM386865U (en) Residue-filtering structure of juice-extractor
TWM400763U (en) Improved structure of cold-accumulating cravats